Bexson Biomedical
Developer of a subcutaneous ketamine delivery system designed to address the limitations of current ketamine preparations to allow control of overdosing and reduced the need for monitoring.
Currently, there are no issues on this topic.
Find more companies like Bexson Biomedical
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
